APA (7th ed.) Citation

Visconti, A., Rossi, N., Deriš, H., Lee, K. A., Hanić, M., Trbojević-Akmačić, I., . . . Weersma, R. K. (2023). Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-10511-3

Chicago Style (17th ed.) Citation

Visconti, Alessia, et al. "Total Serum N-glycans Associate with Response to Immune Checkpoint Inhibition Therapy and Survival in Patients with Advanced Melanoma." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-10511-3.

MLA (9th ed.) Citation

Visconti, Alessia, et al. "Total Serum N-glycans Associate with Response to Immune Checkpoint Inhibition Therapy and Survival in Patients with Advanced Melanoma." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-10511-3.